Protalix BioTherapeutics, Inc. — Institutional Ownership

Which tracked institutions hold PLX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

15
Funds holding
$14055417
Total value held
Buying
11 added/new · 3 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $7848807 3616962 -30144 -0.83%
2 State Street Corp $2111009 972815 +387554 +66.22%
3 Northern Trust Corp $1921422 885448 +19740 +2.28%
4 Morgan Stanley $654890 301793 +169806 +128.65%
5 Goldman Sachs Group Inc $545418 251345 -11464 -4.36%
6 Bank Of New York Mellon Corp $475896 219307 +8440 +4.00%
7 Bank Of America Corp /De/ $171601 79079 +32727 +70.61%
8 Wells Fargo & Company/Mn $142204 79002 +36171 +84.45%
9 Invesco Ltd. $91013 50563 +5560 +12.35%
10 Barclays Plc $32164 14822 NEW BUY
11 Prudential Financial Inc $21939 10110 NEW BUY
12 Equitable Holdings, Inc. $20070 11150 NEW BUY
13 Royal Bank Of Canada $16000 7568 NEW BUY
14 Citigroup Inc $2941 1634 -4980 -75.29%
15 Pnc Financial Services Group, Inc. $43 20 Held

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.